Evidence map›Paper›PMID 20074552›Full record

ArticleBiochemical and biophysical research communications2010

Formation of C-terminally truncated version of the Taz1 protein employs cleavage-box structure in mRNA.

Stanislava Gunisova, Zdenka Bartosova, Juraj Kramara, Jozef Nosek, Lubomir Tomaska

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stanislava GunisovaDepartment of Genetics, Comenius University, 842 15 Bratislava, Slovakia.
Zdenka Bartosova
Juraj Kramara
Jozef Nosek
Lubomir Tomaska
Comenius University Bratislava · SK

Funding

Studies of Telomere Structure Using Yeast Model SystemsR03TW005654 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GRIFFITH, JACK D · 2001 to 2008
$227k
FIC NIH HHS 2-R03-TW005654-04A1FIC NIH HHS R03 TW005654Howard Hughes Medical Institute 55005622
6 · The paper itself

Abstract

When expressed in various hosts the taz1(+) gene encoding the fission yeast telomere-binding protein produces two forms of polypeptides: full-length (Taz1p) and truncated (Taz1pDeltaC) version lacking almost entire Myb-domain. Whereas Taz1p binds telomeric DNA in vitro, Taz1pDeltaC forms long filaments unable of DNA binding. The formation of Taz1pDeltaC is a result of neither site-specific proteolysis, nor premature termination of transcription. In silico analysis of the taz1(+) RNA transcript revealed a stem-loop structure at the site of cleavage (cleavage box; CB). In order to explore whether it possesses inherent destabilizing effects, we cloned CB sequence into the open reading frame (ORF) of glutathione-S-transferase (GST) and observed that when expressed in Escherichia coli the engineered gene produced two forms of the reporter protein. The formation of the truncated version of GST was abolished, when CB was replaced with recoded sequence containing synonymous codons thus indicating that the truncation is based on structural properties of taz1(+) mRNA.

Indexed as

Nucleic Acid ConformationAutophagy-Related ProteinsChromosomal Proteins, Non-HistoneGlutathione TransferaseProtein BiosynthesisRNA, MessengerSchizosaccharomycesSchizosaccharomyces pombe ProteinsSequence Analysis, RNATranscription FactorsTranscription, Geneticatg11 protein, S pombeAutophagy-Related ProteinsChromosomal Proteins, Non-HistoneGlutathione TransferaseRNA, MessengerSchizosaccharomyces pombe ProteinsTranscription Factors

Identifiers

PMID20074552
PMCPMC2846270
OpenAlexW2032986527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.